Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy’s and its ilk start producing the generic version of semaglutide, Nomura says. Dr Reddy’s Laboratories Ltd. is…

Report for Building Road to Ultimate Healthcare Assurance in Approaching Vikshit Bharat

Indian School of Public Policy (ISPP) has unveiled the Seminal Exposition New Delhi: The ultimate level of healthcare is a sine qua non for a developed country. Efforts are afoot…

Dr. Reddy seeks nod for DCGI approval for Phase 3 clinical trials of Sputnik V in India

Dr Reddy’s Laboratories has applied permission to the Drugs Controller General of India (DCGI) for conducting the phase-3 human clinical trials of Sputnik V, Russian coronavirus vaccine against COVID-19 in…

A Top Paediatrician’s Prescription on Parenting

New Delhi: Picture a child scared by the sight of a syringe. It needs quite a coaxing to prepare him or her to be amenable to an injection. The same…

5 Trillion Swagger and Challenges of Making Health in India

New Delhi: As we bask post Union Budget under the swagger of becoming 5 trillion strong economy in the next 5 years of Modi 2.0, it is most opportune that…